Echinacea purpurea in the prevention of acute upper respiratory tract infections in children: a ramdomised, double-blind, placebo-controlled, multicentre trial

Knop Laboratories (Chile)0 个研究点目标入组 308 人开始时间: 2011年1月21日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Male/female healthy children aged 2 years to 4 years 11 months
•2. Participants must be registered in just one of the seven centres of the study
•3. A responsible adult must care him/her 24 hours/7 days of the child
•4. Only one child per family may be enrolled
•5. Parents must sign Informed Conset

•1. Children with any cronic pathology or immune system disease
•2. Allergy to Asteraceae family (coneflowers, sunflowers)
•3. Viral or bacterial disease, related or not to ARI, diarrhoea, vomiting or digestive symptoms at start date
•4. Hepatic or renal insuficiency
•5. Surgery or treatment with drugs that modify immunological system until 60 days previous to start date

发起方

Knop Laboratories (Chile)